Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified) | CEB-Y29c-100ug

Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified) | CEB-Y29c-100ug| Gentaur Distribution US, UK & Europe

Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.

Source: AntiN/ACetuximab Antibody (12B1E9) (CEBN/AY29c) is a monoclonal antibody recombinantly expressed from human 293 cells (HEK293) . The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and BN/Alymphocytes obtained from a mouse immunized with Cetuximab ADA.

Molecule: Cetuximab.

Species: Mouse.

Tag: Mouse IgG1 | Kappa.

Conjugate: Unconjugated.

Purity: 90%.

Charactirization: 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5.

Storage Conditions: -20℃.

Shipping Conditions: RT